# Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus

> **NCT02052531** · PHASE2 · COMPLETED · sponsor: **Amorepacific Corporation** · enrollment: 74 (actual)

## Conditions studied

- Skin Pruritus

## Interventions

- **DRUG:** PAC-14028
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT02052531
- **Lead sponsor:** Amorepacific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2015-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052531, "Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02052531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*